Chemotherapy-induced cell cycle arrest is associated with increased claudin-18 isoform 2 expression and enhanced zolbetuximab-mediated cytotoxicity in gastric cancer
Journal of Gastroenterology · 2026
DOI: 10.1007/s00535-026-02443-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, 2026. Verfasst von Chiaki Takiguchi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Cell Cycle Checkpoints, Claudins, Antineoplastic Agents. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: Claudin-18 isoform 2 (CLDN18.2) is a tight junction protein expressed in gastric mucosa and gastric cancer (GC) cells. Although chemotherapeutic agents are suggested to increase CLDN18.2 expression in GC cells, their impact on GC tissues and their underlying mechanisms remain unclear. METHODS: We examined the effects of chemotherapy on CLDN18.2 expression in human GC tissues and cell lines, and investigated the role of cell-cycle regulation in this process. RESULTS: We found that CLDN18.2 expression was upregulated in GC tissues after chemotherapy. In GC cell lines (SNU-601, NUGC4, GSU), chemotherapeutic agents, including 5-fluorouracil, irinotecan, paclitaxel, and cisplatin, increased CLDN18.2 expression at the transcriptional level, although the response patterns varied among cell lines and agents. Since cell-cycle regulation appeared to be involved, we tested cyclin-dependent kinase (CDK) inhibitors and found that CDK1- and CDK4/6-specific inhibitors similarly enhanced CLDN18.2 expression. Importantly, both chemotherapeutic agents and CDK inhibitors significantly increased zolbetuximab-mediated antibody-dependent cellular cytotoxicity in GC cells. CONCLUSION: These results suggest that chemotherapeutic agents upregulate CLDN18.2 in GC cells at least in part through cell cycle arrest, and support combining zolbetuximab with chemotherapy and/or CDK inhibitors for GC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan. ipsho555@gmail.com.
- Department of Multidisciplinary Treatment of Cancer and Regional Medical Support, Fukushima Medical University, 1 Hikariga-Oka, Fukushima City, Fukushima, 960-1295, Japan. ipsho555@gmail.com.
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Multidisciplinary Treatment of Cancer and Regional Medical Support, Fukushima Medical University, 1 Hikariga-Oka, Fukushima City, Fukushima, 960-1295, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Takiguchi, C., Nakajima, S., Matsuida, H., Hanayama, H., Matsuishi, A., Saito, K., Hayashishita, S., Mitsui, D., Fujii, A., Yamaguchi, D., Saito, M., Okayama, H., Mimura, K., Nakano, H., Kikuchi, T., Saze, Z., Momma, T., Sekine, R., & Kono, K. (2026). Chemotherapy-induced cell cycle arrest is associated with increased claudin-18 isoform 2 expression and enhanced zolbetuximab-mediated cytotoxicity in gastric cancer. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02443-z
Vancouver
Takiguchi C, Nakajima S, Matsuida H, Hanayama H, Matsuishi A, Saito K, et al. Chemotherapy-induced cell cycle arrest is associated with increased claudin-18 isoform 2 expression and enhanced zolbetuximab-mediated cytotoxicity in gastric cancer. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02443-z
BibTeX
@article{Takiguchi2026,
author = {Takiguchi, Chiaki and Nakajima, Shotaro and Matsuida, Hajime and Hanayama, Hiroyuki and Matsuishi, Akira and Saito, Katsuharu and Hayashishita, Sohei and Mitsui, Dai and Fujii, Ayumi and Yamaguchi, Daiki and Saito, Motonobu and Okayama, Hirokazu and Mimura, Kosaku and Nakano, Hiroshi and Kikuchi, Tomohiro and Saze, Zenichiro and Momma, Tomoyuki and Sekine, Rei and Kono, Koji},
title = {Chemotherapy-induced cell cycle arrest is associated with increased claudin-18 isoform 2 expression and enhanced zolbetuximab-mediated cytotoxicity in gastric cancer},
journal = {Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s00535-026-02443-z}
}
EUVIMED